• Exchange: New York
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Teva Pharmaceutical Industries Ltd

+ Add to Watchlist

TEVA:US

53.2100 USD 0.0500 0.09%

As of 20:04:05 ET on 10/22/2014.

Snapshot for Teva Pharmaceutical Industries Ltd (TEVA)

Open: 52.9900 Day's Range: 52.8800 - 54.0500 Volume: 3,597,287
Previous Close: 53.2600 52wk Range: 36.2600 - 55.7000 1-Yr Rtn: +35.63%

Stock Chart for TEVA

No chart data available.
  • TEVA:US 53.2100
  • 1D
  • 1M
  • 1Y
53.2600
Interactive TEVA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TEVA

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 10.8925
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) 4.8850
Est. PEG Ratio 4.1401
Market Cap (M USD) 45,441.34
Shares Outstanding (M) 854.00
30 Day Average Volume 4,066,213
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 2.57%
Cash Dividend (USD) 0.2911
Dividend Ex-Date 08/19/2014
5 Year Dividend Growth 20.83%
Next Earnings Announcement 10/30/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TEVA

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for TEVA

Teva Pharmaceutical Industries Ltd., is a global pharmaceutical company. The Company develops, manufactures, and markets generic and branded human pharmaceuticals as well as active pharmaceutical ingredients.

Erez VigodmanPresident/CEOItzhak KrinskyChairman:Teva Japan & South Korea
Allan ObermanPresident & CEO:AmericasJudith VardiPresident & CEO:Emia & Asia Pacific
More Company Profile & Key Executives for TEVA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil